193-39-5
Chemical Structure
Indeno[1,2,3-cd]pyrene
- CAS No.: 193-39-5
- Formula:C22H12
- Molecular Weight:276.33
IUPAC Name: indeno[1,2,3-cd]pyrene
InChIKey: SXQBHARYMNFBPS-UHFFFAOYSA-N
SMILES: C12=C3C(C4=C2C=CC=C4)=CC5=CC=CC6=CC=C(C3=C56)C=C1
Biological Activity: Indeno[1,2,3-cd]pyrene is a polycyclic aromatic hydrocarbon with moderate cytotoxicity in human pulmonary alveolar epithelial cells HPAEpiC. Indeno[1,2,3-cd]pyrene enhances allergic lung infammation via aryl hydrocarbon receptor[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Indeno[1,2,3-cd]pyrene | 99.66% | Indeno[1,2,3-cd]pyrene is a polycyclic aromatic hydrocarbon with moderate cytotoxicity in human pulmonary alveolar epithelial cells HPAEpiC. Indeno[1,2,3-cd]pyrene enhances allergic lung infammation via aryl hydrocarbon receptor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Indeno[1,2,3-cd]pyrene (Standard) | ≥98% | Indeno[1,2,3-cd]pyrene (Standard) is the analytical standard of Indeno[1,2,3-cd]pyrene. This product is intended for research and analytical applications. Indeno[1,2,3-cd]pyrene is a polycyclic aromatic hydrocarbon with moderate cytotoxicity in human pulmonary alveolar epithelial cells HPAEpiC. Indeno[1,2,3-cd]pyrene enhances allergic lung infammation via aryl hydrocarbon receptor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Indeno[1,2,3-cd]pyrene-d12 | Indeno[1,2,3-cd]pyrene-d12 is the deuterium labeled Indeno[1,2,3-cd]pyrene. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Ke S, et al. An in vitro cytotoxicities comparison of 16 priority polycyclic aromatic hydrocarbons in human pulmonary alveolar epithelial cells HPAEpiC. Toxicol Lett. 2018 Jun 15;290:10-18. [Content Brief]
- [2]. Wong TH, et al. A prominent air pollutant, Indeno[1,2,3-cd]pyrene, enhances allergic lung inflammation via aryl hydrocarbon receptor. Sci Rep. 2018 Mar 26;8(1):5198. [Content Brief]